Refael Avitan
Research And Development Engineer at Cardiovalve | Israel
Refael Avitan’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Research And Development Engineer at Cardiovalve in March 2023 - Present
R&D Mechanical Engineer at Momentis Surgical™ in March 2021 - February 2023
R&D Mechanical Engineer at Syqe Medical in July 2017 - July 2020
R&D Mechanical Engineer at IntoVision in June 2015 - July 2017
Mechanical Engineer at Arnir A.T communication in December 2014 - May 2015
Mechanical Designer at Yakir-Lotem in June 2013 - December 2014
Afeka Tel Aviv Academic College of Engineering, Bachelor of Science (B.Sc.), July 2026
Amit, High School, July 1999 to July 2026
Venus Medtech is a prominent player in transcatheter technologies for structural heart disease therapies. Our comprehensive solutions treat all four heart valves within the human heart (TAVR, TPVR, TMVR, TTVR) in addition to hypertrophic cardiomyopathy, hypertensive renal denervation therapy. Founded in 2009 and headquartered in Hangzhou National High-Tech Industrial Development Zone (Binjiang), the company successfully listed on the Main Board of the Hong Kong Stock Exchange (stock code: 2500.HK) in December 2019. Our journey began with the launch of our first product in 2014, under the New Bioprosthetic Aortic Valve Project in China. We followed this with the introduction of the VenusP-Valve in Europe in 2022. We partner with the top physicians across every continent to understand their challenges and identify opportunities. These insights drive novel breakthrough solutions for a better tomorrow. We invest more than $200M in R&D every year, operate in more than 650 centers worldwide, hold a portfolio of more than 800 patents, and boast a track record of more than 13,000 real-world implantations. As a global leader in the making, Venus Medtech's strategic focus is and will always remain to pioneer innovative technology and equip physicians with the tools they need to enhance the quality of life for patients worldwide.
Discover more about Cardiovalve
CEO at Cardiovalve
Cardiovalve was acquired by Venus MedTech Inc. (Venus MedTech, 2500.HK) an exit of $300M in 2022.
Operations leader
Vice President Operations at Cardiovalve
(Nov 2020 – Present)
Therapy Development Manager
Cardiovalve Therapy Development Manager South Europe at Venus Medtech International
(May 2022 – Present)
International Marketing Director @ Venus Medtech
International Marketing Director at Venus Medtech International
(Aug 2024 – Present)
marketing & training for cardiovascular (science)
The current brand project ❤️
Structural Heart Training Specialist
Therapy development training specialist at Cardiovalve
(Mar 2023 – Present)
What is Refael Avitan email address?
Email Refael Avitan at [email protected] and [email protected]. This email is the most updated Refael Avitan's email found in 2026.
How to contact Refael Avitan?
To contact Refael Avitan send an email to [email protected] or [email protected]. (updated on December 27, 2025)
What company does Refael Avitan work for?
Refael Avitan works for Cardiovalve.
What is Refael Avitan's role at Cardiovalve?
Refael Avitan is Research And Development Engineer
What industry does Refael Avitan work in?
Refael Avitan works in the Mechanical Or Industrial Engineering industry.
